AIA®-CL1200
Powerful and Flexible Immunoassay Testing: The AIA-CL1200 is the mid-size analyzer, ideal for medium and large hospitals and clinics, reference labs and core labs. With a throughput of up to 120 results/h, assay time of 15 min for most analytes, advanced automation features, and excellent analytical performance, it offers a unique solution to labs and it improves patient outcomes.
Cups loading drawers
Tips loading
Receive your quote directly from the manufacturer.
Features:
- Throughput: Up to 120 tests/hour
- Continuous loading with on-board capacity of up to: 100 samples 480 tips 640 twin cups
- Up to 20 analytes per sample
- Walk away time ~ 3.5 hours
- More than 50 analytes onboard
- Long calibration stabilities (90 days for all assays)
- Reagent Cooling ≤ 15°C
- STAT position
- Automated daily maintenance
- Optional: Automatic dilution device for buffer preparation
Tosoh’s immunoassay range offers a unique solution to labs with advanced automation and improved patient outcomes
Brochures
Diagnosis made clear through Presepsin testing
This brochure explores the clinical utility of Presepsin (sCD14-ST), a biomarker that rises early during bacterial infection and sepsis. Discover how Presepsin testing can support early diagnosis, ongoing treatment monitoring, and risk stratification, providing clinicians with valuable information alongside other diagnostic tools as part of a comprehensive sepsis management strategy.
The assay is available on AIA®-360 and AIA®-CL300 analyzers from Tosoh Bioscience - Diagnostics EMEA, delivering results in approximately 15–20 minutes for rapid clinical decision-making in emergency and critical care settings. The brochure also outlines the biological role of Presepsin in the innate immune response and its growing evidence base in sepsis diagnosis and prognosis.
Resource details
- Resource type: Product brochure
- Page count: 8
- Read time: 12 mins
